Pathological margins and advanced cutaneous squamous cell carcinoma of the head and neck

Abstract Objective The recommended treatment for cutaneous squamous cell cancer (CuSCC) of the head and neck is Mohs surgical excision or wide local excision. Excision is recommended to a gross surgical margin of 4–6 mm however this is based on limited evidence and specify a goal histologic margin....

Full description

Saved in:
Bibliographic Details
Main Authors: T. J. Phillips, B. N. Harris, M. G. Moore, D. G. Farwell, A. F. Bewley
Format: Article
Language:English
Published: SAGE Publishing 2019-10-01
Series:Journal of Otolaryngology - Head and Neck Surgery
Online Access:http://link.springer.com/article/10.1186/s40463-019-0374-3
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832568875325063168
author T. J. Phillips
B. N. Harris
M. G. Moore
D. G. Farwell
A. F. Bewley
author_facet T. J. Phillips
B. N. Harris
M. G. Moore
D. G. Farwell
A. F. Bewley
author_sort T. J. Phillips
collection DOAJ
description Abstract Objective The recommended treatment for cutaneous squamous cell cancer (CuSCC) of the head and neck is Mohs surgical excision or wide local excision. Excision is recommended to a gross surgical margin of 4–6 mm however this is based on limited evidence and specify a goal histologic margin. The objective of this study was therefore to examine the reported histological margin distance following WLE of advanced CuSCC and its association with recurrence and survival. Study design Retrospective database review. Setting All patients included received treatment at UC Davis Department of Otolaryngology-Head and Neck Surgery and/or Radiation Oncology in Sacramento, California. Subjects and methods The patients included were treated for advanced CuSCC with primary surgery with or without adjuvant therapy. Kaplan Meier survival curves with log rank analysis were then performed to compare 5-year recurrence free survival, and disease-specific survival for patients with different margin distances. Results Total number of subjects was 92. The overall 5-year DSS and RFS was 68.8 and 51.0% respectively. When the pathological margin distance was ≥5 mm, 5-year disease specific survival was improved when compared to margin distance less than 5 mm (94.7 vs 60.7 p = 0.034). Conclusion The findings of this study suggest that a histologic margin of at least 5 mm may increase survival in advanced head and neck CuSCC patients.
format Article
id doaj-art-d41c2a6783f047449e57953d6729d8b0
institution Kabale University
issn 1916-0216
language English
publishDate 2019-10-01
publisher SAGE Publishing
record_format Article
series Journal of Otolaryngology - Head and Neck Surgery
spelling doaj-art-d41c2a6783f047449e57953d6729d8b02025-02-03T00:22:58ZengSAGE PublishingJournal of Otolaryngology - Head and Neck Surgery1916-02162019-10-014811610.1186/s40463-019-0374-3Pathological margins and advanced cutaneous squamous cell carcinoma of the head and neckT. J. Phillips0B. N. Harris1M. G. Moore2D. G. Farwell3A. F. Bewley4Department of Otolaryngology-Head and Neck Surgery, UC DavisDepartment of Otolaryngology-Head and Neck Surgery, UC DavisDepartment of Otolaryngology-Head and Neck Surgery, UC DavisDepartment of Otolaryngology-Head and Neck Surgery, UC DavisDepartment of Otolaryngology-Head and Neck Surgery, UC DavisAbstract Objective The recommended treatment for cutaneous squamous cell cancer (CuSCC) of the head and neck is Mohs surgical excision or wide local excision. Excision is recommended to a gross surgical margin of 4–6 mm however this is based on limited evidence and specify a goal histologic margin. The objective of this study was therefore to examine the reported histological margin distance following WLE of advanced CuSCC and its association with recurrence and survival. Study design Retrospective database review. Setting All patients included received treatment at UC Davis Department of Otolaryngology-Head and Neck Surgery and/or Radiation Oncology in Sacramento, California. Subjects and methods The patients included were treated for advanced CuSCC with primary surgery with or without adjuvant therapy. Kaplan Meier survival curves with log rank analysis were then performed to compare 5-year recurrence free survival, and disease-specific survival for patients with different margin distances. Results Total number of subjects was 92. The overall 5-year DSS and RFS was 68.8 and 51.0% respectively. When the pathological margin distance was ≥5 mm, 5-year disease specific survival was improved when compared to margin distance less than 5 mm (94.7 vs 60.7 p = 0.034). Conclusion The findings of this study suggest that a histologic margin of at least 5 mm may increase survival in advanced head and neck CuSCC patients.http://link.springer.com/article/10.1186/s40463-019-0374-3
spellingShingle T. J. Phillips
B. N. Harris
M. G. Moore
D. G. Farwell
A. F. Bewley
Pathological margins and advanced cutaneous squamous cell carcinoma of the head and neck
Journal of Otolaryngology - Head and Neck Surgery
title Pathological margins and advanced cutaneous squamous cell carcinoma of the head and neck
title_full Pathological margins and advanced cutaneous squamous cell carcinoma of the head and neck
title_fullStr Pathological margins and advanced cutaneous squamous cell carcinoma of the head and neck
title_full_unstemmed Pathological margins and advanced cutaneous squamous cell carcinoma of the head and neck
title_short Pathological margins and advanced cutaneous squamous cell carcinoma of the head and neck
title_sort pathological margins and advanced cutaneous squamous cell carcinoma of the head and neck
url http://link.springer.com/article/10.1186/s40463-019-0374-3
work_keys_str_mv AT tjphillips pathologicalmarginsandadvancedcutaneoussquamouscellcarcinomaoftheheadandneck
AT bnharris pathologicalmarginsandadvancedcutaneoussquamouscellcarcinomaoftheheadandneck
AT mgmoore pathologicalmarginsandadvancedcutaneoussquamouscellcarcinomaoftheheadandneck
AT dgfarwell pathologicalmarginsandadvancedcutaneoussquamouscellcarcinomaoftheheadandneck
AT afbewley pathologicalmarginsandadvancedcutaneoussquamouscellcarcinomaoftheheadandneck